chr9-137096361-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016219.5(MAN1B1):​c.590C>T​(p.Pro197Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0195 in 1,613,756 control chromosomes in the GnomAD database, including 1,145 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 96 hom., cov: 32)
Exomes 𝑓: 0.019 ( 1049 hom. )

Consequence

MAN1B1
NM_016219.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.360
Variant links:
Genes affected
MAN1B1 (HGNC:6823): (mannosidase alpha class 1B member 1) This gene encodes an enzyme belonging to the glycosyl hydrolase 47 family. This enzyme functions in N-glycan biosynthesis, and is a class I alpha-1,2-mannosidase that specifically converts Man9GlcNAc to Man8GlcNAc isomer B. It is required for N-glycan trimming to Man5-6GlcNAc2 in the endoplasmic-reticulum-associated degradation pathway. Mutations in this gene cause autosomal-recessive intellectual disability. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 11. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0012768805).
BP6
Variant 9-137096361-C-T is Benign according to our data. Variant chr9-137096361-C-T is described in ClinVar as [Benign]. Clinvar id is 129580.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-137096361-C-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0921 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MAN1B1NM_016219.5 linkuse as main transcriptc.590C>T p.Pro197Leu missense_variant 4/13 ENST00000371589.9 NP_057303.2
MAN1B1XM_006716945.5 linkuse as main transcriptc.590C>T p.Pro197Leu missense_variant 4/12 XP_006717008.1
MAN1B1NR_045720.2 linkuse as main transcriptn.605C>T non_coding_transcript_exon_variant 4/13
MAN1B1NR_045721.2 linkuse as main transcriptn.736C>T non_coding_transcript_exon_variant 5/14

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MAN1B1ENST00000371589.9 linkuse as main transcriptc.590C>T p.Pro197Leu missense_variant 4/131 NM_016219.5 ENSP00000360645 P2

Frequencies

GnomAD3 genomes
AF:
0.0192
AC:
2927
AN:
152216
Hom.:
95
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00485
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0958
Gnomad ASJ
AF:
0.0199
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0186
Gnomad FIN
AF:
0.00518
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0147
Gnomad OTH
AF:
0.0201
GnomAD3 exomes
AF:
0.0374
AC:
9355
AN:
250174
Hom.:
785
AF XY:
0.0312
AC XY:
4231
AN XY:
135506
show subpopulations
Gnomad AFR exome
AF:
0.00520
Gnomad AMR exome
AF:
0.194
Gnomad ASJ exome
AF:
0.0186
Gnomad EAS exome
AF:
0.000272
Gnomad SAS exome
AF:
0.0179
Gnomad FIN exome
AF:
0.00643
Gnomad NFE exome
AF:
0.0136
Gnomad OTH exome
AF:
0.0259
GnomAD4 exome
AF:
0.0195
AC:
28482
AN:
1461422
Hom.:
1049
Cov.:
32
AF XY:
0.0187
AC XY:
13628
AN XY:
726976
show subpopulations
Gnomad4 AFR exome
AF:
0.00400
Gnomad4 AMR exome
AF:
0.180
Gnomad4 ASJ exome
AF:
0.0205
Gnomad4 EAS exome
AF:
0.000277
Gnomad4 SAS exome
AF:
0.0183
Gnomad4 FIN exome
AF:
0.00702
Gnomad4 NFE exome
AF:
0.0151
Gnomad4 OTH exome
AF:
0.0162
GnomAD4 genome
AF:
0.0193
AC:
2933
AN:
152334
Hom.:
96
Cov.:
32
AF XY:
0.0203
AC XY:
1513
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.00483
Gnomad4 AMR
AF:
0.0961
Gnomad4 ASJ
AF:
0.0199
Gnomad4 EAS
AF:
0.000579
Gnomad4 SAS
AF:
0.0186
Gnomad4 FIN
AF:
0.00518
Gnomad4 NFE
AF:
0.0147
Gnomad4 OTH
AF:
0.0198
Alfa
AF:
0.0147
Hom.:
23
Bravo
AF:
0.0278
TwinsUK
AF:
0.0121
AC:
45
ALSPAC
AF:
0.0127
AC:
49
ESP6500AA
AF:
0.00590
AC:
26
ESP6500EA
AF:
0.0135
AC:
116
ExAC
AF:
0.0311
AC:
3775
Asia WGS
AF:
0.0120
AC:
43
AN:
3478
EpiCase
AF:
0.0125
EpiControl
AF:
0.0132

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 14, 2013- -
Benign, criteria provided, single submitterclinical testingGenomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of PhiladelphiaMay 05, 2015- -
Rafiq syndrome Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 12, 2019- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 11, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
0.42
DANN
Benign
0.89
DEOGEN2
Benign
0.023
T;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.051
N
LIST_S2
Benign
0.59
T;T
MetaRNN
Benign
0.0013
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-1.1
N;.
REVEL
Benign
0.060
Sift
Benign
0.098
T;.
Sift4G
Benign
0.31
T;T
Polyphen
0.59
P;.
Vest4
0.069
MPC
0.087
ClinPred
0.0032
T
GERP RS
-3.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.026
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61744585; hg19: chr9-139990813; COSMIC: COSV63034911; COSMIC: COSV63034911; API